Ganoderma lucidum – Page 18

Transcription factor FfMYB15 regulates the expression of cellulase gene FfCEL6B during mycelial growth of Flammulina filiformis

mycolabadmin

This study explores how mushrooms break down cellulose to grow. Researchers found that a protein called FfMYB15 acts as a master switch that turns on the gene for an enzyme (cellulase) needed to digest cellulose in the Flammulina filiformis mushroom. By controlling this enzyme, FfMYB15 helps the mushroom grow faster and more efficiently on cellulose-rich materials used in cultivation.

Effects of Environmental and Nutritional Conditions on Mycelium Growth of Three Basidiomycota

mycolabadmin

Researchers tested how three types of edible and medicinal mushroom fungi grow on different substrate mixtures to develop better biodegradable materials for packaging and insulation. They found that substrates rich in cotton fibers combined with specific carbon dioxide levels produced the fastest and densest fungal growth. These findings help optimize the production of eco-friendly mushroom-based materials that could replace plastic and foam products while being fully compostable.

Functionalized Micellar Membranes from Medicinal Mushrooms as Promising Self-Growing Bioscaffolds

mycolabadmin

Scientists created special membranes from medicinal mushrooms that can help heal wounds and regenerate damaged skin. These membranes are grown naturally in liquid culture and enriched with extract from mango peels to fight bacteria and promote healing. The material is completely natural, biodegradable, and performs better than many conventional wound healing materials, making it an eco-friendly option for medical applications.

Research Progress of Polysaccharide-Gold Nanocomplexes in Drug Delivery

mycolabadmin

Scientists are combining polysaccharides (natural compounds found in plants and organisms) with tiny gold particles to create better drug delivery systems. These hybrid nanoparticles can transport medicines directly to cancer cells while reducing side effects and improving treatment effectiveness. The review discusses how these gold-polysaccharide combinations can also fight bacteria and viruses, making them useful for various medical applications beyond cancer therapy.

Potential Usage of Edible Mushrooms and Their Residues to Retrieve Valuable Supplies for Industrial Applications

mycolabadmin

Edible mushrooms are not only nutritious foods but also contain valuable compounds that are being wasted during production. Scientists are discovering new ways to use mushroom waste to make useful products like natural skincare items, water purification materials, and food additives. These innovations help reduce environmental pollution while creating valuable products, supporting a more sustainable circular economy.

Ganoderma lucidum and Robinia pseudoacacia Flower Extract Complex Alleviates Kidney Inflammation and Fibrosis by Modulating Oxidative Stress

mycolabadmin

Researchers studied a natural supplement made from reishi mushroom and black locust flower to treat kidney disease. In laboratory and animal tests, this supplement reduced kidney damage by lowering harmful molecules called free radicals and controlling inflammation. The supplement worked by blocking specific pathways that cause kidney inflammation and scarring, suggesting it could be a helpful natural treatment for people with chronic kidney disease.

Isolation, purification, and structural elucidation of Stropharia rugosoannulata polysaccharides with hypolipidemic effect

mycolabadmin

Scientists extracted and studied a polysaccharide from wine cap mushrooms that shows promise for lowering cholesterol and protecting the liver. The compound, called SRF-3, has a complex sugar structure and works by binding to cholesterol and bile acids, helping the body eliminate them. Testing in laboratory conditions showed it has strong antioxidant properties and can reduce fat accumulation in liver cells, suggesting potential use as a natural supplement for managing high cholesterol.

Biosynthesis of mushroom-derived type II ganoderic acids by engineered yeast

mycolabadmin

Scientists successfully engineered baker’s yeast to produce ganoderic acids, potent anti-cancer compounds from medicinal mushrooms, at much higher levels than found in farmed mushrooms. By identifying key enzymes responsible for converting simpler compounds into active ganoderic acids, researchers created yeast strains that produce these valuable compounds 100-10,000 times more efficiently than traditional mushroom farming. This breakthrough could make these expensive medicinal compounds more accessible and affordable for medical research and potential drug development.

Transcriptome Analysis Explored the Differential Genes’ Expression During the Development of the Stropharia rugosoannulata Fruiting Body

mycolabadmin

Researchers studied how S. rugosoannulata mushrooms grow and develop by analyzing which genes are active at different stages of fruit body formation. They found that the mushroom’s development relies heavily on glucose and amino acid metabolism, with special genetic processes called alternative splicing playing key roles in maturation. This is the first comprehensive genetic study of this edible mushroom’s development, providing valuable information for improving cultivation techniques and mushroom quality.

Extracellular Biosynthesis, Characterization and Antimicrobial Activity of Silver Nanoparticles Synthesized by Filamentous Fungi

mycolabadmin

Researchers used three types of common fungi to create tiny silver particles in an environmentally friendly way. These silver nanoparticles were found to effectively kill harmful bacteria and fungal infections. The fungus Cladosporium cladosporoides was the most effective at producing these particles, showing promise for use in medical and health applications.

Fungal Species: Ganoderma lucidum